Phase III clinical trial - Prostate

TRITON3 (CO-338-063)
Prostate
Ouvert depuis le: 07.16.2019
Site: Paris
Public cible
Adulte
A Study of Rucaparib Versus Physician's Choice of Therapy in Patients With Metastatic Castration-resistant Prostate Cancer and Homologous Recombination Gene Deficiency.
Description de l'essai

The purpose of this study is to determine how patients with metastatic castration-resistant prostate cancer, and evidence of a homologous recombination gene deficiency, respond to treatment with rucaparib versus treatment with physician's choice of abiraterone acetate, enzalutamide, or docetaxel.